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of different types of infusates (normal saline, hemaccel and blood) on cerebral hemodynamics
and oxygenation during brain tumor resection.
Methods: 60 patients scheduled for the resection of brain tumor were included. They were ran-
domly classiﬁed into three groups by closed envelope randomization (n= 20) according to type
of maintenance ﬂuid, Crystalloid (normal saline), colloid (hemaccel) and blood group. Anesthesia
was induced using thiopental sodium 5–7 mg/kg, atracurium to facilitate intubation and isoﬂurane
for maintenance. Hemodynamics and oxygen parameters including Cerebral metabolic rate for oxy-
gen (CMRO2), Cerebral oxygen extraction (CEO2), Cerebral blood ﬂow equivalent (CBFe) were
recorded after induction, 30 min, 1 h, 1.5 h, 2 h and at closure of the dura.
Results: In comparison to the basal value, lactate and glucose displayed signiﬁcant increase at 1
and 2 h in crystalloid and blood group. CMRO2 in the blood group showed an intra-group327080.
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68 S.A. Mousa et al.signiﬁcant increase when compared to the basal value. Both CMRO2 and CEO2 displayed a signif-
icant increase in the blood group at the second hour in comparison to the colloid group while CEO2
was signiﬁcantly dropped in the colloid group from 1 h till the end when compared to the crystalloid
group. CBFe displayed signiﬁcant decrease in crystalloid and blood groups in comparison to the
colloid group from 1 h till after closure.
Conclusion: Colloid is an effective maintenance infusate during brain tumor resection as it accom-
panied with a signiﬁcant increase in SjO2 which might be explained with an increase in cerebral
delivery of oxygen and a decrease in CMRO2 consumption. Also colloid group is the only group
that did not alter the blood lactate level throughout the study period. Lastly, it was observed that
ﬂow-metabolism coupling was maintained with colloid group only, where as the coupling was dis-
turbed in the other two groups.
ª 2011 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Brain tumors represent a major medical problem due to the
complex effects either locally on the brain or on different body
systems. These effects were produced by alteration of the cere-
bral blood ﬂow either directly through compression of the
adjacent vessels or indirectly via increased intra-cranial pres-
sure and generation of new unhealthy vessels that lack all cere-
brovascular properties as barrier mechanisms, carbon dioxide
(CO2) responsiveness and autoregulatory capacities [1].
In neurosurgery, preoperative fasting, induction of general
anesthesia, the use of diuretics and bleeding may decrease intra-
vascular volume, blood pressure and/or cerebral perfusion pres-
sure (CPP) as well as compromise perfusion of other organs [2].
The corner stone of intra-operative ﬂuid administration is to
maintain adequate oxygen delivery, normal electrolyte concen-
trations, adequacy of vital organ perfusion and to maintain pa-
tients’ euglycemic [3]. Fluid replacement in cranial surgery
should be limited to glucose free isotonic crystalloid as normal
saline or colloid solutions. Controversy still surrounds the
choice between crystalloid and colloid solutions [4].
Colloids available in the markets are either polysaccharides
or polypeptides; the latter prepared from a chemically modi-
ﬁed collagen [5]. Hemaccel is a synthetic polygeline that has
been used as a volume replacement. One of the advantages
of hemaccel over other colloids like dextran or hetastarch is
the respect of blood clotting [6,7]. These generations of gelatins
help to ﬁll the gap that exists between crystalloids and blood
products [8]. Blood transfusions are usually given to increase
oxygen-carrying capacity and intravascular volume. However,
increasing oxygen-carrying capacity is the only real indication
for blood transfusion [9].
Monitoring of jugular venous oxygen saturation (SjO2) has
been shown to be useful in the intensive care of comatosed
head-injured patients and in the intra-operative treatment of
patients undergoing neurosurgical procedures [10]. Intra-oper-
ative monitoring of cerebral hemodynamics is very difﬁcult.
Jugular bulb cannulation and sampling helped a lot in this as-
pect. Measurements of jugular venous oxygen saturation have
been used to assess cerebral oxygenation and metabolism that
may alter CBF [11]. Crystalloids, colloids and blood, as infu-
sates, have different compositions, viscosities, acidic activities,
oxygen-carrying capacities and electrolyte constituents. All
these differences can affect the integrity of the delicate cerebral
hemodynamics and metabolism. So, the aim of this study was
to evaluate the efﬁcacy and the effects of different types of
infusates in patients subjected to brain tumor resection.2. Patients and methods
This prospective randomized study was conducted after ap-
proval by the local ethical committee of Department of Anes-
thesia and Surgical Intensive Care, Faculty of Medicine,
Mansoura University. Randomization was done through
closed envelope method. This study was carried out on 60 pa-
tients of either sex with an age ranging from 20 to 60 years.
These patients admitted to the department of Neurosurgery
in Mansoura University Hospital for elective resection of
supratentorial brain tumors (47 right sided tumor and 13 left
sided tumor). They were randomly classiﬁed into 3 equal
groups according to the type of the maintenance ﬂuid used.
All patients have given a written informed consent prior to
enrollment.
Patients with cardiac or respiratory insufﬁciency, severe he-
patic or renal impairment, hypertension, uncontrolled diabetes
mellitus, severe polyurea of any cause (e.g. diabetes insepidus),
CPAT (cerebello – pontine angle tumor), recent history of intra-
cranial hemorrhage, and patients with moderate and severe in-
creased intra-cranial pressure, all are excluded from this study.
The day before surgery all patients were evaluated fulﬁlling
full medical history, clinical examination, chest X-ray and
ECG. Laboratory investigations included complete blood pic-
ture and hematocrit, serum creatinine, serum bilirubin, albu-
min, SGOT, SGPT, prothrombin time and activity, INR and
blood glucose.
On the day of surgery and after their arrival to the operat-
ing theater two wide bore intravenous cannulae (18 G) were in-
serted through suitable peripheral veins. I.V. midazolam
0.05 mg/kg and I.V. fentanyl 1.5 lg/kg 10 min before induc-
tion were given and an incremental dose of fentanyl was re-
peated according to the hemodynamic proﬁle. The maximum
dose of fentanyl reached up to 200 lg.
Preanesthetic monitoring included pulse, ECG, blood pres-
sure (non-invasive), and peripheral O2 saturation.
2.1. Induction of anesthesia
Pre-oxygenation with 100% O2 for 5 min then anesthesia was
induced using I.V. thiopental sodium 5–7 mg/kg. With the loss
of consciousness, positive pressure ventilation was provided
via a face mask at a rate of 12–15 breathes/minute. The trachea
was intubated with a suitable cuffed endotracheal tube 2 min
after an induction dose of atracurium besylate (0.5 mg/kg) to
facilitate intubation, followed by top up doses of 1/5 of the ini-
tial dose of atracurium for maintenance of muscle relaxation.
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air using Dragger (Fabius GS-Germany) ventilator with tidal
volume of 8–10 ml/kg and I/E ratio 1:2 through closed circuit
with fresh gas ﬂow around 3 l. End-tidal CO2 was monitored
by main stream capnograph. Minute ventilation was modiﬁed
to keep EtCO2 around 30 mm Hg.
2.2. Maintenance
Anesthesia was maintained with a mixture of oxygen:air (1:1)
and isoﬂurane (from 0.6 to 1). Fentanyl administration was re-
peated if needed. Mannitol (20%) was given in a dose of 1 gm/
kg starting with the scalp incision in all groups.
2.3. Cannulation
 Arterial cannula (20 G): it was inserted into the radial
artery of the non-dominant hand (after performance of
modiﬁed Allen’s test) under aseptic conditions for repeated
arterial blood gas sampling.
 vvCentral venous catheter (18 G): A single lumen catheter
(Amecath, France) was inserted in the right subclavian vein
with strict sterile technique using Sildenger technique. The
catheter was then ﬂushed with heparinized normal saline
solution and connected to a pressure transducer for central
venous pressure monitoring. The position of the catheter
was conﬁrmed by anterio-posterior chest X-ray just after
insertion by C-arm.
 Jugular bulb catheter: The patients were placed ﬂat in
supine position with slight extension of the neck. The head
was in neutral position or slightly tilted away from the side
of insertion. Antiseptic solution was applied to the neck and
upper thoracic area. The anatomical landmarks for the
internal jugular vein was identiﬁed (lateral to a palpable
internal carotid artery, medial to the sternomastoid muscle,
at the level of cricoid cartilage, where at this site, internal
jugular vein is more or less superﬁcial and could be easily
accessible. The internal jugular vein (right side in 59
patients and left in one patient where we met difﬁculty for
right sided cannulation) was then cannulated per cutane-
ously lateral to the artery by retrograde insertion of a 16-
gauge catheter(Amecath, France). The catheter was then
advanced towards the external auditory meatus using Sild-
enger technique till the resistance of the base of the skull is
reached (at which, about 10–15 cm of the catheter was
inserted). The catheter was then withdrawn for about 1–
2 mm [13].The position of the catheter was conﬁrmed by
antero-posterior and lateral neck X-ray just before skin
incision by C-arm.2.4. Fluid regimen
Patients were randomly allocated (closed envelop method) into
three equal groups according to the type of infusate used.
2.4.1. The ﬁrst group (crystalloid) (n = 20)
It wasmaintainedwith crystalloid solution (normal saline 0.9%)
from the start, guided by CVP values and urine volume and no
blood was given unless there was a severe blood loss (more than
20%of total blood volume) and/or hematocrit value<30%and
in this case the patient was excluded from the study.2.4.2. The second group (colloid) (n = 20)
It was maintained with colloid solution (Hemaccel solution)
from the start (maximum volume was 1000 ml all through
the 2 h of the study), guided by CVP and urine volume and
no blood was given even with blood loss till our lower hemat-
ocrit limit (30%) was reached or with severe blood loss (more
than 20% of total blood volume).2.4.3. The third group (blood) (n = 20)
It was maintained with blood, any blood loss is replaced by
blood transfusion from the start of operation, guided by
CVP and urine volume.
 From our knowledge, there were no study that uses the
blood as a sole infusate for maintenance ﬂuid therapy dur-
ing brain tumor resection. So the rationale for the use of
blood in this group is to assess the blood effect on the rhe-
ology of cerebral circulation that might consequently inﬂu-
ence cerebral hemodynamics and oxygenation.
 This policy of ﬂuid therapy was maintained for 2 h, then the
routinely used regimen was adopted (crystalloid ± blood
transfusion guided by blood loss, CVP and urine output).2.5. Monitoring and sampling
2.5.1. Hemodynamics and oxygen parameters
Heart rate (HR), ECG monitoring, non–invasive arterial
blood pressure (NABP), arterial oxygen saturation (SaO2;
using pulse oxymetry), end tidal carbon dioxide (ETCO2)
and central venous pressure (CVP).
 The above mentioned parameters were recorded immedi-
ately after induction and every 30 min till the end of surgery
using Drager (Inﬁnity Kappa, Mexico) monitor with Sam-
sung screen.2.5.2. Laboratory assessment
Blood gases using blood Gas System (AVL 990, Austria) and
the samples taken from radial artery and jugular bulb immedi-
ately after induction (after stabilization of ETCO2 between 30
and 35 mm Hg) then at 30, 60, 90 and 120 min after induction
and lastly after ﬁnishing the surgical procedure.
 Both jugular bulb and arterial blood samples were collected
in heparinized syringes and kept in ice till they were
analyzed.
Hb and HCT value using Automatic Cell Counter (Sysmex
Kx-21, Japan) and blood glucose level: using Cobas Integra
800 (Roche, Germany) were assessed.
Serum lactates (from jugular bulb) were taken immediately
after induction, 60 and 120 min.
Lactate Samples: 3 mL blood samples were collected on
ﬂuoride, immediately stored at 2–8 C, transported to the hos-
pital’s laboratory and then lactate was measured.2.5.3. Calculated parameters
(a) Estimated cerebral metabolic rate for oxygen (eCMRO2)
was calculated as the product of PaCO2 and arterio-jug-
ular oxygen content difference [14].
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(b) Cerebral oxygen extraction ratio (CEO2) was calculated
as the difference between arterial and jugular oxygen
saturation [11,15].CEO2 ¼ SpO2  SjO2 ð2Þ
(c) Cerebral blood ﬂow equivalent (CBFe) is an index of
ﬂow metabolism relationship and it was calculated as a
reciprocal of arterio-jugular oxygen content difference
[16,17].CBF equivalent ¼ 1
a-jDO2
ð3Þ
(d) Blood losses were calculated through measuring the vol-
ume of the blood in suction apparatus, socked surgical
towels and gauze.2.6. Postoperative period
The patient was transferred to a surgical intensive care for at
least 24 h with full monitoring, and any complications were re-
corded (either intra-operative or postoperative).
2.7. Data analysis
The power of this clinical trial was retrospectively calculated
using the G Power analysis program version 3.[12] Using
post-hoc power analysis with accuracy mode calculations
and assuming type-I error protection of 0.05 and medium ef-
fect size convention of 0.3, a total sample size of 60 patients
produced a power of 0.78.
Statistical Package of Social Science (SPSS), version 10, was
used for analysis of data of this study. Distribution of data
(normality) was identiﬁed using a Kolmogrov–Smirnov test.
Normally distributed data (ratio and interval-scale data) were
subjected to ANOVA test followed by L.S.D. (as a post-hoc)Table 1 Patients characteristics and duration of surgery of
(min–max), ratio (M/F).
Crystalloid (G I) (n= 20)
Age (years) 36.6 ± 12.50 (20–55)
Sex (M/F) (8/12)
Duration of surgery (h) 3.15 ± 1.46 (2–7)
Table 2 Perioperative heart rate ‘‘HR’’ (bpm) and mean arterial bl
mean ± SD.
Time HR (bpm)
G I (crystalloid) G II (colloid) G I
Before induction (Basal) 89 ± 12.5 83 ± 8.3 88 ±
Immed. post-induction 93 ± 13.7 93 ± 10.0* 91 ±
0.5 h 86 ± 13.9 82 ± 10.9 86 ±
1 h 84 ± 12.2 84 ± 12.1 85 ±
1.5 h 86 ± 13.6 83 ± 10.4 86 ±
2 h 89 ± 13.2 87 ± 13.2 85 ±
After closure 95 ± 14.3 90 ± 14.4* 87 ±
* P< 0.05: signiﬁcant when compared to the basal value of the same grtest to identify the presence or absence of signiﬁcance, either
in inter- or intra-group multiple comparisons. Data (ratio
and interval-scale) deviated from normal distribution, as well
as ordinal data, were analyzed using Kruskal–Wallis test (mul-
tiple comparisons) followed by Mann–Whitney test for single
comparison.
Chi-square test was used to identify signiﬁcant differences
between nominal data (e.g. sex as a datum). Any difference
or change showing probability (P) less than 0.05 was consid-
ered statistically signiﬁcant.
3. Results
Patients were randomly classiﬁed into 3 equal groups; group I
(crystalloid group, n= 20), group II (colloid group, n= 20),
and group III (blood group, n= 20). Patients in the 3 studied
groups showed no signiﬁcant changes concerning the demo-
graphic data (age, sex) as well as duration of surgery (Table 1).
3.1. Hemodynamic parameters
Perioperative HR and MAP did not differ signiﬁcantly during
the whole study period when comparing all groups to each
other. However, some intra-group signiﬁcant differences were
noticed in the 3 groups in comparison to the basal values (Ta-
ble 2). Regarding CVP, there were no signiﬁcant changes de-
tected between all groups throughout the whole study
period. However, in comparison to the basal value in same
group, both colloid and blood groups demonstrated a signiﬁ-
cant elevation in the last two readings of the study (Table 3).
3.2. Hematological changes
Both Hb and HCT were signiﬁcantly decreased in both crystal-
loid and colloid groups but signiﬁcantly increased in blood
group in comparison to the corresponding basal values ofthe studied groups. Values are presented as mean ± SD,
Colloid (G II) (n= 20) Blood (G III) (n= 20)
42.3 ± 11.07 (20–60) 41.15 ± 7.80 (25–53)
(11/9) (9–11)
2.75 ± 0.91 (2–5) 3.15 ± 0.93 (2–5)
ood pressure ‘‘MAP’’ (mm Hg) for studied groups. Values are in
MAP (mm Hg)
II (blood) G I (crystalloid) G II (colloid) G III (blood)
11.8 90 ± 11.3 91 ± 8.6 94 ± 8.1
9.9 83 ± 14.1* 86 ± 12.6* 87 ± 12.4*
13.6 87 ± 10.2 89 ± 10.8 92 ± 8.7
9.7 84 ± 8.9 84 ± 12.0* 88 ± 8.8*
9.9 84 ± 7.3 84 ± 10.6* 88 ± 8.7*
11.7 88 ± 6.8 87 ± 8.8* 89 ± 9.9*
15.2 94 ± 9.2 97 ± 10.7* 99 ± 8.5*
oup.
Table 3 Central venous pressure (CVP) of the studied groups.
Values are in mean + SD.
Time CVP (mm Hg)
G I
(crystalloid)
G II
(colloid)
G III
(blood)
Immed. post-induction
(Basal)
0.1 ± 1.0 0.1 ± 0.8 0.2 ± 0.8
0.5 h 0.1 ± 1.1 0.1 ± 0.7 0.3 ± 0.4
1 h 0.0 ± 0.9 0.2 ± 0.8 0.1 ± 0.7
1.5 h 0.2 ± 0.8 0.1 ± 0.8 0.3 ± 0.8
2 h 0.1 ± 0.9 0.5 ± 0.6* 0.4 ± 0.7*
After
closure
0.5 ± 1.1 0.7 ± 0.8* 0.8 ± 0.8*
* P< 0.05: signiﬁcant when compared to the basal value of the
same group.
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period except in blood group for HCT that showed no signif-
icant changes in comparison to the basal value. Meanwhile, a
signiﬁcant rise in both Hb and HCT was noticed during the
whole study period in the blood group when compared to
the other two groups (Table 4).
3.3. Blood lactate and glucose
There were intra-group signiﬁcant increases of blood lactate in
crystalloid as well as in blood group in comparison to the basal
value at 1 and 2 h. Blood glucose displayed signiﬁcant increase
in the three studied groups 1 and 2 h in comparison to basal
values. (Table 5).
Blood lactate showed a signiﬁcant increase in the blood
group when compared to the colloid group at the second hour
intraoperatively. Similarly, blood glucose displayed signiﬁcant
increase in blood group in comparison to the colloid group at
2 h of surgery (Table 5).
3.4. Blood gases variables
SpO2 displayed no signiﬁcant alternations in the 3 studied
groups at all study periods in comparison to the basal value
and in-between the groups. Similarly, SjO2 showed no signiﬁ-
cant differences compared to the basal value. However, there
were some signiﬁcant changes detected between the 3 studied
groups in SjO2. In comparison to the crystalloid group, thereTable 4 Perioperative haemoglobin (gm/dl) and hematocrit (%) fo
Time Hemoglobin (gm/dl)
G I (crystalloid) G II (colloid) G III
Before induction (Basal) 12.0 ± 1.6 11.8 ± 1.5 12.8 ±
Immed. post-induction 12.2 ± 1.5 11.8 ± 1.5 12.8 ±
0.5 h 11.9 ± 1.5 11.6 ± 1.5* 13.1 ±
1 h 11.6 ± 1.5* 11.4 ± 1.6* 13.4 ±
1.5 h 11.3 ± 1.6* 11.2 ± 1.6* 13.5 ±
2 h 11.1 ± 1.7* 11.0 ± 1.8* 13.6 ±
After closure 11.6 ± 1.5* 11.4 ± 1.4* 13.5 ±
* P< 0.05: signiﬁcant when compared to the basal value of the same gr
** P< 0.05: signiﬁcant when compared to group I at the same event.
*** P< 0.05: signiﬁcant when compared to group II at the same event.were signiﬁcant increases in SjO2 at all intra-operative periods
and at the ﬁrst 2 readings in both the colloid and blood groups,
respectively. However, in comparison to the colloid group, the
blood group showed a signiﬁcant reduction in SjO2 only at the
second hour intraoperatively (Table 6).
Between 1 and 2 h intraoperatively, there was a signiﬁcant
reduction in the value of PaO2 in blood group if compared
with the corresponding readings in the crystalloid and colloid
groups. Meanwhile and in comparison to the basal readings,
PaO2 displayed a signiﬁcant rise starting from 1 h and from
1.5 h till the end of the study in crystalloid and colloid group
respectively (Table 7).
As regards PjO2, it showed a signiﬁcant drop in blood
group between the ﬁrst and second hours intraoperatively
when compared to the basal reading and only at the second
hour in comparison to colloid group. However, a signiﬁcant
increase in PjO2 was noticed in the colloid group at the last
two intra-operative readings in comparison to crystalloid
group (Table 7). Regarding PaCO2 and PjCO2, it can be
clearly seen that values of both variables maintained without
any signiﬁcant changes within the whole monitored periods
in comparison to the basal value and in-between the groups
(Table 8).
In comparison to the basal readings, CaO2 displayed signif-
icant decrease in the crystalloid and colloid groups whereas it
showed signiﬁcant increase in the blood group nearly at all in-
tra-operative monitored periods. CjO2 in the crystalloid group
displayed signiﬁcant decrease in comparison to the basal value
at all monitored times. In addition, in comparison to the crys-
talloid and colloid groups, a signiﬁcant elevation in both CaO2
and CjO2 was observed in the blood group nearly throughout
the whole study period (Table 9).
3.5. Calculated cerebral values
CMRO2 showed signiﬁcant increase in the blood group nearly
during the whole study period in comparison to the basal va-
lue. On comparing the 3 studied groups, both CMRO2 and
CEO2 displayed a signiﬁcant increase in the blood group at
the second hour intraoperatively in comparison to the colloid
group while CEO2 was signiﬁcantly dropped in the colloid
group from 1 h intraoperatively till the end of the study period
when compared to crystalloid group (Table 10).
Only in the blood group, CBFe was signiﬁcantly reduced
when compared with the basal value in the same group during
the study period. On comparing the 3 studied groups, CBFer the studied groups. Values are in mean + SD.
Hematocrit (%)
(blood) G I (crystalloid) G II (colloid) G III (blood)
1.3 39.0 ± 4.4 38.4 ± 4.2 41.8 ± 3.9
1.3 39.3 ± 4.1 38.5 ± 4.1 41.9 ± 4.0
1.2*,**,*** 38.4 ± 3.6 38.1 ± 3.8 42.5 ± 3.9**,***
1.3*,**,*** 37.5 ± 3.6* 37.3 ± 4.0* 42.9 ± 4.4**,***
1.2*,**,*** 36.5 ± 3.9* 37.1 ± 4.4* 43.5 ± 3.9**,***
1.3*,**,*** 35.6 ± 4.5* 36.6 ± 5.5* 44.2 ± 4.1**,***
1.4*,**,*** 37.3 ± 4.1* 37.2 ± 4.2* 43.9 ± 4.1**,***
oup.
Table 5 Perioperative jugular venous blood lactate (mmol/l) and blood glucose (mg/dl) for the studied groups. Values are in
mean ± SD.
Time Blood lactate (mmol/l) Blood glucose (mg/dl)
G I (crystalloid) G II (colloid) G III (blood) G I (crystalloid) G II (colloid) G III (blood)
Before induction (Basal for glucose) 93 ± 19 95 ± 24 102 ± 27
Immed. post-induction (Basal for lactate) 0.15 ± 0.05 0.16 ± 0.08 0.17 ± 0.05 91 ± 19 98 ± 30 108 ± 38
0.5 h
1 h 0.19 ± 0.07 * 0.18 ± 0.07 0. 20 ± 0.05* 112 ± 19* 136 ± 50* 156 ± 59*,**
1.5 h
2 h 0.22 ± 0.09 * 0.19 ± 0.06 0.26 ± 0.07*,*** 129 ± 26* 152 ± 45* 190 ± 69*,**,***
After closure
* P< 0.05: signiﬁcant when compared to the basal value of the same group.
** P< 0.05: signiﬁcant when compared to group I at the same event.
*** P< 0.05: signiﬁcant when compared to group II at the same event.
Table 6 Measured arterial oxygen saturation ‘‘SpO2’’ (%) and jugular oxygen saturation ‘‘SjO2’’ (%) for the studied groups (from
ABG). Values are in mean ± SD.
Time SpO2 (%) SjO2 (%)
G I (crystalloid) G II (colloid) G III (blood) G I (crystalloid) G II (colloid) G III (blood)
Immed. post-induction (Basal) 98.3 ± 1.16 98.9 ± 0.85 98.4 ± 1.19 68.6 ± 9.96 74.3 ± 8.69 75.1 ± 10.84**
0.5 h 98.2 ± 1.28 98.9 ± 1.07 98.9 ± 1.37 67.1 ± 9.13 73.2 ± 8.57** 74.9 ± 10.36**
1 h 98.4 ± 1.09 98.9 ± 0.98 98.4 ± 1.72 67.1 ± 7.36 73.7 ± 8.42** 70.4 ± 10.86
1.5 h 98.5 ± 1.60 99.0 ± 0.86 98.7 ± 0.85 68.0 ± 8.23 74.3 ± 8.82** 70.8 ± 10.06
2 h 98.7 ± 1.14 99.2 ± 0.83 98.8 ± 0.86 68.2 ± 6.39 75.9 ± 8.05** 69.8 ± 10.24***
After closure 98.7 ± 0.82 99.2 ± 0.86 99.0 ± 0.77 67.3 ± 8.59 74.9 ± 7.54** 70.8 ± 11.15
** P< 0.05: signiﬁcant when compared to group I at the same event.
*** P< 0.05: signiﬁcant when compared to group II at the same event.
Table 7 Measured arterial oxygen tension ‘‘PaO2’’ (mm Hg) and jugular oxygen tension ‘‘PjO2’’ (mm Hg) of the studied groups (from
ABG). Values are in mean ± SD.
Time PaO2 (mm Hg) PjO2 (mm Hg)
G I (crystalloid) G II (colloid) G III (blood) G I (crystalloid) G II (colloid) G III (blood)
Immed. post-induction (Basal) 167.8 ± 58.9 161.5 ± 33.3 159.0 ± 64.1 38.8 ± 7.7 45.9 ± 11.2 46.3 ± 13.9
0.5 h 176.1 ± 56.5 156.4 ± 35.7 152.6 ± 47.3 39.7 ± 8.2 43.8 ± 9.5 44.7 ± 9.4
1 h 189.3 ± 44.6* 169. 3 ± 31.4 145.9 ± 31.6**,*** 39.8 ± 7.2 44.4 ± 9.1 41.1 ± 7.8*
1.5 h 207.3 ± 47.4* 185.4 ± 41.6* 154.4 ± 33.8**,*** 41.1 ± 10.8 43.9 ± 9.8 41.9 ± 9.1*
2 h 199.9 ± 39.2* 186.1 ± 32.7* 160.6 ± 36.2**,*** 39.9 ± 6.5 46.9 ± 8.9** 41.7 ± 8.5 *,***
After closure 210.4 ± 42.6* 210.6 ± 73.5* 189.7 ± 77.9 39.3 ± 7.7 45.9 ± 8.3** 44.7 ± 11.1
* P< 0.05: signiﬁcant when compared to the basal value of the same group.
** P< 0.05: signiﬁcant when compared to group I at the same event.
*** P< 0.05: signiﬁcant when compared to group II at the same event.
72 S.A. Mousa et al.demonstrated a signiﬁcant elevation in the colloid group in
comparison to other groups (Table 10).
4. Discussion
In the present study, 3 ﬂuid regimens were compared, crystal-
loid (0.9% saline), colloid (Hemaccel), and blood during intra-
cranial surgery for excision of cerebral mass lesions. The threeinfusates were investigated regarding intra-operative cerebral
and systemic hemodynamic proﬁle and cerebral oxygenation.
Under general anesthesia, drug effects, surgical stimulus,
changes in posture, temperature and blood volume inﬂuence
autonomic functions [18]. Thus, it would seem probably that
changes of HR and MAP differ with different ﬂuid regimens
reﬂecting indirect variable effects of different infusates on the
autonomic and cardio-respiratory activities.
Table 8 Measured arterial carbon dioxide tension ‘‘PaCO2’’ (mm Hg) and jugular carbon dioxide tension ‘‘PjCO2’’ (mm Hg) of the
studied groups (from ABG). Values are in mean ± SD.
Time PaCO2 (mm Hg) PjCO2 (mm Hg)
G I (crystalloid) G II (colloid) G III (blood) G I (crystalloid) G II (colloid) G III (blood)
Immed. post-induction (Basal) 32.8 ± 3.54 34.4 ± 5.22 33.1 ± 3.83 41.9 ± 11.69 41.8 ± 7.35 39.7 ± 6.01
0.5 h 32.2 ± 3.47 34.1 ± 3.31 32.9 ± 3.73 40.3 ± 11.11 40.1 ± 5.77 38.2 ± 5.04
1 h 31.8 ± 3.39 32.8 ± 3.91 33.0 ± 4.38 39.1 ± 5.04 40.7 ± 5.81 41.8 ± 6.20
1.5 h 31.9 ± 3.33 32.7 ± 4.33 32.5 ± 3.47 40.3 ± 9.64 39.7 ± 5.21 40.4 ± 6.32
2 h 32.6 ± 2.93 34.5 ± 4.18 33.2 ± 5.20 40.4 ± 10.24 41.4 ± 6.41 41.6 ± 7.04
After closure 34.0 ± 4.14 35.8 ± 4.46 35.0 ± 4.97 42.2 ± 9.03 42.1 ± 4.54 42.0 ± 5.68
Table 9 Arterial oxygen content ‘‘CaO2’’ (ml/dl) and jugular oxygen content ‘‘CjO2’’ (ml/dl) of the studied groups. Values are in
mean ± SD.
Time CaO2 (ml/dl) CjO2 (ml/dl)
G I (crystalloid) G II (colloid) G III (blood) G I (crystalloid) G II (colloid) G III (blood)
Immed. post-induction (Basal) 16.5 ± 2.01 16.1 ± 1.91 17.4 ± 1.62*** 11.3 ± 1.98 11.6 ± 1.69 12.9 ± 2.04**,***
0.5 h 16.1 ± 1.86* 15.9 ± 2.00* 17.7 ± 1.56*,**,*** 10.7 ± 1.23 11.5 ± 1.62 13.2 ± 2.17**,***
1 h 15.8 ± 1.94* 15.6 ± 2.13* 18.0 ± 1.62*,**,*** 10.4 ± 1.23* 11.3 ± 1.45 12.7 ± 2.31**,***
1.5 h 15.6 ± 1.94* 15.4 ± 2.22* 18.3 ± 1.53*,**,*** 10.5 ± 1.78* 11.1 ± 1.65 12.9 ± 2.24**,***
2 h 15.3 ± 2.19* 15.2 ± 2.50* 18.5 ± 1.62*,**,*** 10.3 ± 1.71* 11.3 ± 1.71 12.8 ± 2.34**,***
After closure 16.1 ± 1.92* 15.8 ± 1.92* 18.5 ± 1.73*,**,*** 10.5 ± 1.92* 11.6 ± 1.42 12.9 ± 2.35**,***
* P< 0.05: signiﬁcant when compared to the basal value of the same group.
** P< 0.05: signiﬁcant when compared to group I at the same event.
*** P< 0.05: signiﬁcant when compared to group II at the same event.
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loid group) and MAP (in all groups) showed signiﬁcant
changes (increase in HR but decrease in MAP) from the basal
readings. However, in the next intra-operative readings (where
the HR and MAP decreased), both hemodynamic variables
showed good stability within normal physiological range.
The minimally signiﬁcant decrease in MAP in the 3 studied
groups may be attributed to the relatively decreased systemic
vascular resistance (SVR) as a direct effect of isoﬂurane anes-
thesia used. This result was supported by Cahalan et al. [19]
and Lam and Gelb [20] who proved that isoﬂurane produced
dose-dependent decrease in MAP (by approximately 25% at
1 MAC) when administered to human volunteers due to a de-
crease in the SVR. This may be also due to the myocardial
depression of isoﬂurane [21].
On the other hand, a signiﬁcant elevation of the HR and
MAP was encountered in the current study in the closure value
in the colloid and blood groups, mostly was due to regaining of
consciousness after anesthesia leading to a sympathetically
mediated neuro-endocrinal excitatory response.
The intravascular administration of Hemaccel in the colloid
and blood in blood groups resulted in a signiﬁcant increase of
the CVP, 2 h after induction and immediately after closure,
when compared with the baseline values. This may be attrib-
uted to the proper ﬂuid resuscitation. That is because colloids
and blood remain in the intravascular compartment for long
time compared to crystalloids and can augment the intravascu-
lar volume as conﬁrmed by Ueyama et al., study [22].
As regard the HCT and Hb, signiﬁcant decrease in the crys-
talloid and colloid groups could be explained by the dilutional
effect of the ﬂuid used and/or surgical blood loss withoutimmediate blood transfusion at those times. These ﬁndings
are in agreement with previous ﬁndings that in surgical pa-
tients, low HCT are usually encountered after advanced surgi-
cal blood loss and a sanguineous infusion therapy to maintain
normovolaemia as a result of the effects of dilution with crys-
talloids and colloids [23–25].
Similarly, Tommasino [26] stated that one common accom-
paniment of ﬂuid administration is a reduction in Hb and
HCT. In the face of active blood loss, the use of a sanguineous
ﬂuid can cause some degree of anemia.
Meanwhile, the signiﬁcant rise in Hb and HCT in the blood
group could be explained by the immediate compensation of
any blood loss with blood transfusion, as planned in the study
protocol, which can maintain high Hb and HCT levels inspite
of any blood loss. This is supported by the Niraj et al. [27] who
stated that intra-operative Hb estimation is considered an
effective and simple objective measurement to increase the inci-
dence of appropriate transfusions. It is worth noting that the
least recorded value of Hb was 11.1 gm/dl (crystalloid group)
and 36.5% for HCT (crystalloid group). These two values
are within physiological range and allow very good oxygen
delivery for different tissues.
In this study, signiﬁcant increase in blood lactate was re-
corded in the crystalloid and blood groups (still within physi-
ological range) when compared to basal values. There was a
maximum increase at the second hour in the blood group when
compared to colloid group. In the present study blood lactate
level was used as an index of anaerobic metabolism, i.e., if it
was higher than expected levels this means inadequate oxygen
supply to the brain. This might be attributed to the decreased
SjO2, decreased CBF (associated with increased CEO2) and/or
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74 S.A. Mousa et al.increased metabolism (CMRO2). Also, it may be due to high
level of glucose in these groups that was available for metab-
olism which exceeded the aerobic metabolic capacity. This is
in accordance with previous ﬁndings that hyperglycemia can
correlate to increased cerebral lactate [28,29]. The use of lac-
tate as an indicator of oxygenation imbalance is in agreement
with Ezzat [30], Cruz et al., [31] and Marion [32] who stated
that moderate cerebral ischemia associated with lactate pro-
duction which is used as a reliable indicator of cerebral ische-
mia in acute brain injury. Another point in our explanation
is that elevated lactate in the present study may be due to the
surgery itself [33,34].
On the other hand, our results are contradictory to previ-
ous studies that did not support inadequate systemic oxygen
delivery as a cause of raised lactate levels [35]. Furthermore,
one study found that raised lactate levels were associated
with reduced levels of oxygen extraction and suggested that
peripheral oxygen utilization may be impaired [36].
In comparison to the basal value, the 3 studied groups
demonstrated a signiﬁcant increase in blood glucose values
at 1 and 2 h post-induction. Possible causes include surgical
stress and the effect of anesthesia with changes in catechola-
mines and cortisol level which, in turn, tend to reduce insulin
secretion or to prevent its glucose-lowering effect leading to
hyperglycemia.
This can be supported by Halter and Pﬂug [37] and Ha-
gen et al. [38] who demonstrated that patients undergoing
surgery mount a signiﬁcant stress response, as measured by
the release of catecholamines, corticosteroids (endogenous,
or may be also exogenous from IV steroids used), ADH
and growth hormone, glucagons and the suppression of insu-
lin release. Most of these hormones are hyperglycemic in ac-
tion, either through glycolysis or gluconeogenesis.
On the other hand, the intra-operative signiﬁcant increase
in glucose level in the blood group in comparison to the
other two groups could be attributed to the presence of dex-
trose as a preservative in the blood to provide red cell energy.
The increase in SjO2 in colloid and blood groups in rela-
tion to crystalloid group may be due to the increase in oxy-
gen delivery to the brain by colloids infusion or blood
transfusion (not with crystalloids).This explanation is in
accordance with Pe´rez et al. [39] who stated that the increase
in SjO2 occurs with an increase in cerebral delivery of oxygen
or a decrease in CMRO2 consumption.
On other hand, it could be suggested that reduced values
of SjO2 in the blood group at the second hour of the study in
comparison to colloid group results mainly from any factor
that decreases cerebral delivery of oxygen, e.g., reduction of
the CBF or hyperventilation and/or an increase in the cere-
bral metabolic activity. Similar ﬁndings were demonstrated
in other studies where a decrease in the SjO2 (high a-jDO2)
represents an increase in CEO2 which may result from sys-
temic hypoxia, low CBF secondary to hypotension or cere-
bral vasospasm or increased ICP (may be caused by mass
lesions, diffuse brain edema) or hyperventilation (hypocap-
nia) as SjO2 is highly related to PaCO2 [39,40].
Arterial oxygen tension (PaO2) rise in crystalloid group
proves that pulmonary function is not affected adversely
by crystalloid resuscitation [41] or with fewer pulmonary
complications and hemodynamic stability [42]. Moreover,
lymphatic ﬂow can increase up to 20 times, which explains
Cerebral hemodynamics and oxygenation during brain tumor resection: A comparative study 75why the additional ﬂuid given during crystalloid resuscitation
does not normally cause pulmonary edema [43].
As regards PjO2, our ﬁndings (higher with colloid than with
crystalloid) may be attributed to improved microcirculation,
less tissue swelling and less pulmonary complications with col-
loid infusion. Our ﬁndings correlate with the results of Lang
et al. [44] as regards colloidal PO2 increase, but are contradic-
tory to their results as regards crystalloidal PO2 (as it increases
in our study). They investigated the effects of a colloid-based
versus a crystalloid-based intravascular volume replacement
regimen on tissue oxygenation in patients undergoing major
abdominal surgery. They noticed that colloid resuscitation
was associated with an increase in perioperative tissue PO2,
whereas it is decreased in patients who were resuscitated with
crystalloid. Improved microcirculation and less endothelial
swelling may be responsible for the better PO2 with colloids.
In our study, SaO2, jugular and arterial PCO2 in the three
studied groups showed no signiﬁcant changes and were within
accepted physiological ranges throughout the study period.
This is indicating good ventilation and oxygenation of all pa-
tients with controlled ventilation that maintained the ETCO2
around 30 mm Hg.
A signiﬁcant elevation in both CaO2 and CjO2 was ob-
served in the blood group nearly throughout the whole study
period in comparison to crystalloid and colloid groups and
in comparison to the basal value in CaO2. This increased O2
content may be caused by the blood transfusion which led to
increased Hb level observed in the blood group. This explana-
tion can be supported by the fact that blood is transfused to
increase oxygen content and improve oxygen delivery, thereby
preventing tissue hypoxia. In the absence of clinically reliable
direct measurements of adequate tissue oxygenation, Hb con-
centration is commonly used instead [27].
The decrease in CaO2 and CjO2 in crystalloid and colloid
groups may be due to a signiﬁcant decrease in Hb level (dilu-
tional effect). This is because these types of ﬂuids share in vol-
ume but not in oxygen carriage.
In this study, the blood group showed a signiﬁcant steady
increase in CMRO2 when compared to the basal value. On
the other hand, crystalloid and colloid groups showed more
or less stable CMRO2 all through the study period which is
a better outcome neurologically. This stability can be attrib-
uted to better rheology of the blood (decreased viscosity),
more stable blood ﬂow with subsequent more efﬁcient supply
of cerebral oxygen and substrates. This explanation depending
on viscosity changes can be conﬁrmed by a previous study that
proved a signiﬁcant decrease in blood viscosity using crystal-
loids and colloids [3].
The blood group, in this study, showed a signiﬁcant de-
crease in CBFe all through the study time in comparison to
the basal values (disturbed coupling). The colloid group (as
well as crystalloid group) showed good stability when com-
pared to the basal values, meanwhile it showed signiﬁcantly
higher values when compared to both the crystalloid and
blood groups. An explanation for the increased CBF in the
colloid group may be the signiﬁcantly decreased HCT (with
decreased blood viscosity) by Hemaccel infusion. This is can
be supported by other studies where a decrease in HCT (e.g.
in anemia), cerebral vascular resistance is reduced and CBF in-
creases, i.e., a decrease in HCT improves CBF. This is attrib-
uted to decreasing blood viscosity [45,46]. This is because
organ blood ﬂow (maintained by ﬂuid resuscitation) is deter-mined by the perfusion pressure, vascular resistance and blood
viscosity [47] which, in turn, can inﬂuence CBF. As HCT is the
single most important determinant of blood viscosity, changes
in HCT lead to substantial changes in CBF [45]. A further sup-
port of our ﬁndings is that volume replacement with Hemaccel
markedly reduced HCT and viscosity [3].
Potential explanation for this decrease inCBF inbloodgroup
from the basal value could be related to an increase in the viscos-
ity and HCT of blood as a result of blood transfusion without
any ﬂuid infusion. This was conﬁrmed by Brian et al., [48] who
stated that elevated HCT (as in patients with polycythemia)
can reduce CBF as a result of increased blood viscosity.
This current study had certain limitations that include rela-
tively small number of patients, limitation of the study time to
2 h, different surgeons. We could not ﬁx the surgeons and so
the duration of the surgery and the severity of bleeding varied
from one surgeon to another which might have its effect on
hemodynamics and oxygenation variables. Other limitations
include, inability to measure ICP, inability to blind the study,
limited groups of patients, and no ﬂuids combination group.
Continuous monitoring and measurement of cerebral
parameters are very important as much as those of systemic
parameters. According to the monitored variables with the po-
sitive and negative ﬁndings of the studied infusates, we can
shift from one regimen of infusate to another. Future studies
in this ﬁeld should continue trying to exclude limitations and
drawbacks of this study through near perfect research design.5. Conclusion
Inspite of the continuous practice that used crystalloid as a
main infusate during neurosurgery, colloids (hemaccel in our
study) has a hopeful future to be use as an effective mainte-
nance infusate during brain tumor resection as it accompanied
with a signiﬁcant increase in SjO2 which might be due to an in-
crease in the oxygen delivery to the brain and a decrease in
CMRO2 consumption. Also colloid group is the only group
that did not alter the blood lactate level through out the study
period. Lastly, it was observed that ﬂow-metabolism coupling
was maintained with the colloid group only.References
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